Eli Lilly has lowered the price of its GLP-1 drug Zepbound (tirzepatide) in single-dose vials, with the starting dose now available for $299 per month

GLP-1 medication, such as Wegovy, was added to the list of ‘essential’ medicines by the World Health Organization in September

The World Health Organization on Monday recommended GLP-1 drugs for adult weight management.

On next-gen GLP-1 drugs. “A mere decade ago, obesity drugs powerful enough for people to routinely drop double-digit percentages of their body weight were unheard-of.

Eli Lilly will shave $50 off the self-pay price for most single-dose vials of its blockbuster weight loss drug Zepbound, about a month after agreeing

A FAT jab could help slow down Alzheimer’s by slashing brain shrinkage, according to a small British study. Liraglutide, the GLP-1 drug already used to manage

November proved to be a tough month for the Marks & Spencer (LSE:MKS) share price. It was one of the worst-performing stocks in the FTSE

This systematic review and meta-analysis assesses the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in children and adolescents with obesity, prediabetes, or

Type 2 diabetes mellitus affects over 38 million Americans, with diabetic kidney disease as a major complication partly driven by lipotoxicity. Fatty acid transport protein

Type 2 diabetes affects more than 38 million people in the United States, and a major complication is kidney disease. During the analysis of lipotoxicity

To the Editor The importance of integrating lifestyle modification when initiating glucagon-like peptide-1 and dual receptor agonists (GLP-1 RAs) for type 2 diabetes and/or obesity

One in five people in the United States live in a rural area. Patients in rural communities often struggle to access care because of travel

New precautions added for GLP-1 drugs as reports of mood changes and contraceptive concerns emerge in Australia.

The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to

Discover four innovative ways food and beverage brands are catering to GLP-1 users — from slow-release nutrition to high-protein drinks and gut health solutions.

New pill versions of weight loss drugs, lower prices, and patent expirations will all drive GLP-1 demand in 2026

The Therapeutic Goods Administration issued a new warning for GLP-1 receptor agonists, including Ozempic and Mounjaro, on Monday.

TGA also issues separate warning around Mounjaro and potential reduced effectiveness of contraception The medicines regulator has added two new safety warnings around mental health

The high-profile weight loss and diabetes drugs will come with two new warnings for patients.

CHRISTMAS will be very merry for three million fat jab users — as they are likely to get drunk quickly. Doctors have issued a festive

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative to injectables. Clinical trials show significant weight loss and

The alarming trend spotted amongst GLP-1 users means some patients cannot lift their limbs due to nerve dysfunction.

The company sharpens its domestic specialty formulations focus and looks to scale APIs through acquisitions, while planning partnership-led GLP-1 launches

I’ve seen clients start GLP-1 medications full of hope, and stop them feeling betrayed by their own biology. Some reached their limit with side effects:

(MedPage Today) — GLP-1 receptor agonists are being linked to a long list of benefits besides weight loss and diabetes, as evidence suggests they can

ABSTRACT Background The emergence of a distinct facial appearance characterized by pronounced hollowing of the cheeks, temples, chin, and periorbital region has become a noteworthy

IJMS, Vol. 26, Pages 11548: From Phytochemistry to Metabolic Regulation: The Insulin-Promoting Effects of Loureirin B Analogous to an Agonist of GLP-1 Receptor International Journal

Healthcare, Vol. 13, Pages 3102: Exploring Adults’ Experiences with Tirzepatide for Weight Loss: A Mixed-Methods Study Healthcare doi: 10.3390/healthcare13233102 Authors: Shukri Adam Fatma M. Ibrahim

Nutrients, Vol. 17, Pages 3735: Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes Nutrients doi: 10.3390/nu17233735

From surgery to supplements, GLP-1 medications are radically evolving the beauty space. We unpack the latest innovations.

Following the White House’s recent announcement of price reductions and expanded coverage for GLP-1 medications like Wegovy and Zepbound, many patients searching for obesity treatments

Its involvement often leads to distortions and perverse incentives. Dr. Gilberto de Lima Lopes Jr. is right that the market for medications is imperfect, but

Diagnostics, Vol. 15, Pages 3025: Beyond BMI: Rethinking Obesity Metrics and Cardiovascular Risk in the Era of Precision Medicine Diagnostics doi: 10.3390/diagnostics15233025 Authors: Maria-Daniela Tanasescu

JCM, Vol. 14, Pages 8413: Epicardial Fat and Heart Failure in Type 2 Diabetes: Metabolism, Imaging and Novel Biomarkers—A Translational Perspective Journal of Clinical Medicine

For individuals taking GLP‑1 medications such as Ozempic, Thanksgiving doesn’t have to be restrictive, but specific foods and beverages need caution. Dietitian Kylie Bensley recommends

submitted by /u/Cough_Geek [link] [comments]